RE:RE:RE:silence3D Director:
Mr. Gordon McCauley was previously the President and CEO of Allon Therapeutics Inc. (TSX: NPC). After the conclusion of a global phase 3 clinical trial that failed, Allon Therapeutics Inc. submitted a proposal under the Bankruptcy and Insolvency Act. This proposal was submitted in the District of British Columbia, Vancouver Division (03), Estate number 11-1753091. Deloitte & Touche Inc. (“Deloitte”) w